entity

🤖 AI-Generated

AB

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

53Connections

30Hypotheses

4Analyses

50Outgoing

0Incoming

11Experiments

3Debates

No AI portrait yet

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Outgoing (53)

Target	Relation	Type	Str
TAU	co_discussed	gene	0.60
AD	activates	gene	0.60
TAU	interacts_with	gene	0.60
AD	co_discussed	gene	0.60
ALZHEIMER'S DISEASE	co_discussed	disease	0.60
APOE	co_discussed	gene	0.60
AΒ	co_discussed	gene	0.60
IBA1	activates	gene	0.60
MICROGLIA	mediates	cell_type	0.60
TREM2	activates	gene	0.60
ENDOTHELIAL	interacts_with	cell_type	0.60
LDLR	interacts_with	gene	0.60
CHAT	transports	gene	0.60
LDLR	mediates	gene	0.60
STING	interacts_with	gene	0.60
ENDOTHELIAL	co_discussed	cell_type	0.60
PDGF	activates	gene	0.60
VEGF	activates	gene	0.60
EGF	associated_with	gene	0.60
PDGF	co_discussed	gene	0.60
VEGF	co_discussed	gene	0.60
PD	expresses	gene	0.60
PD	mediates	gene	0.60
PD	disrupts	gene	0.60
MYC	regulates	gene	0.60
PD	regulates	gene	0.60
STING	regulates	gene	0.60
WNT	inhibits	gene	0.60
PD	co_discussed	gene	0.60
NEURON	co_discussed	cell_type	0.60
MS	co_discussed	gene	0.60
MULTIPLE SCLEROSIS	associated_with	disease	0.60
OLIGODENDROCYTE	associated_with	cell_type	0.60
MS	regulates	gene	0.60
MOG	associated_with	gene	0.60
MS	associated_with	gene	0.60
ACHE	co_discussed	gene	0.60
RAGE	co_discussed	gene	0.60
AUTOPHAGY	mediates	pathway	0.60
PD	degrades	gene	0.60
TREM2	co_discussed	gene	0.60
TREM2	targets	gene	0.60
MICROGLIA	enhances	cell_type	0.60
TREM2	enhances	gene	0.60
AD	targets	gene	0.60
STING	co_discussed	gene	0.60
TAU	activates	gene	0.60
MICROGLIA	activates	cell_type	0.60
NEURON	activates	cell_type	0.60
NEURONS	activates	cell_type	0.60

Incoming (0)

Source	Relation	Type	Str
No incoming edges

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Metabolic Reprogramming to Reverse Senescence	1.000	-	Senescent cell clearance as neurodegener
HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM	0.919	neurodegeneration	How do different microglial subtypes (DA
Palmitoylethanolamide-Based Endocannabinoid Therapy	0.919	-	Blood-brain barrier tight junction disru
Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla	0.892	neurodegeneration	View
Optimized Temporal Window for Metabolic Boosting Therapy Det	0.879	neurodegeneration	How do different microglial subtypes (DA

Optogenetic restoration of hippocampal gamma oscillations vi	0.863	Alzheimer's disease	Circuit-level neural dynamics in neurode
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95	0.861	Alzheimer's disease	Circuit-level neural dynamics in neurode
TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima	0.858	neurodegeneration	How do different microglial subtypes (DA
H6: Aberrant eIF2α Phosphorylation Creates Stalled Translati	0.834	neurodegeneration	How do pathological stress granules tran
Ketone Utilization Index as Metabolic Flexibility Biomarker	0.819	translational neuroscience	Which metabolic biomarkers can distingui
CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-S	0.811	neurodegeneration	What are the cell-type-specific transcri
TREM2-mTOR Co-Agonism for Metabolic Reprogramming	0.803	neurodegeneration	TREM2 agonism vs antagonism in DAM micro
TREM2 Deficiency Drives Microglial Senescence via Lipid Meta	0.800	neurodegeneration	What molecular mechanisms drive microgli
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P	0.796	neurodegeneration	Senolytic therapy for age-related neurod
Competitive APOE4 Domain Stabilization Peptides	0.784	neurodegeneration	APOE4 structural biology and therapeutic
H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from E	0.770	neurodegeneration	Investigate mechanisms of epigenetic rep
LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vul	0.770	Alzheimer's Disease	Cell type vulnerability in Alzheimers Di
APOE4 astrocytes exhibit impaired cholesterol efflux via ABC	0.760	neuroscience	APOE4-driven lipid metabolism dysregulat
Dual-Circuit Tau Vulnerability Cascade	0.754	neuroscience	Circuit-level neural dynamics in neurode
Tau dysfunction destabilizes labile pool	0.750	neurodegeneration	View
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming	0.748	neurodegeneration	Gene expression changes in aging mouse b
C1QA/C1QB Subunit-Specific Inhibition to Block Aberrant PV I	0.747	neurodegeneration	Are interneuron oscillation deficits com
Metabolic NAD+ Salvage Pathway Enhancement Through NAMPT Ove	0.745	neurodegeneration	Epigenetic reprogramming in aging neuron
TREM2-SIRT1 Metabolic Senescence Circuit in Microglial Aging	0.744	neurodegeneration	Gene expression changes in aging mouse b
Smartphone-Detected Motor Variability Correction	0.742	neurodegeneration	Digital biomarkers and AI-driven early d
Metabolic Inflexibility Precedes Transcriptional Reprogrammi	0.735	neurodegeneration	What is the optimal therapeutic window f
Seed-Proximal Asymmetric Duplex Stability Confers lncRNA-002	0.733	molecular neurobiology	View
Metabolic-Support Secretome Dysfunction	0.730	neurodegeneration	Which specific factors in conditioned me
Adenosine-Astrocyte Metabolic Reset	0.730	neurodegeneration	Sleep disruption as cause and consequenc
Metabolic Switch Targeting for A1→A2 Repolarization	0.726	neurodegeneration	Astrocyte reactivity subtypes in neurode

Mentioning Analyses (4)

Scientific analyses that reference this entity

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

neurodegeneration | 2026-04-24 | 5 hypotheses Top: 0.790

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

neurodegeneration | 2026-04-23 | 0 hypotheses

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.619

Metabolomic signatures of neurodegeneration and energy metabolism dysfunction

neurodegeneration | 2026-04-04 | 0 hypotheses

Experiments (11)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
AECII-specific HMGCS2 overexpression in mouse pulmonary fibrosis	validation	idiopathic pulmonary fibrosis	0.950	C57BL/6 mice with AECII-specif	proposed	N/A
SIRPα modulation in mouse models of Alzheimer's disease	validation	Alzheimer's disease	0.900	mouse models of Alzheimer's di	proposed	N/A
NAD depletion effects on monocyte/macrophage differentiation	exploratory	Inflammatory bowel disease	0.900	Primary mouse and human monocy	proposed	N/A
FK866 treatment in DSS-induced colitis mouse model	validation	Inflammatory bowel disease (co	0.900	DSS-induced colitis mice	proposed	N/A
Ketogenic diet fat threshold analysis in wild-type mice	validation	metabolic disease	0.900	C57BL/6J wild-type mice	proposed	N/A
HMGCS2 gain-of-function in AECII lipid metabolism regulation	exploratory	idiopathic pulmonary fibrosis	0.900	human AECIIs	proposed	N/A
Ketogenic diet efficacy in diet-induced obese mice	validation	obesity, metabolic disease	0.900	C57BL/6J diet-induced obese mi	proposed	N/A
Synaptic plasticity and protein expression analysis in mPFC	exploratory	insomnia-anxiety comorbidity	0.850	mPFC brain slices from PCPA-tr	proposed	N/A
FK866 in azoxymethane/DSS colitis-associated cancer model	validation	Colitis-associated cancer	0.850	AOM/DSS-treated mice	proposed	N/A
FK866 mechanism validation in Rag1-/- mice	validation	Inflammatory bowel disease	0.850	Rag1-/- mice with DSS-induced	proposed	N/A
Microarray and single-cell RNA analysis of lipid metabolism genes	exploratory	idiopathic pulmonary fibrosis	0.850	human patients, mouse models	proposed	N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (3)

Multi-agent debates referencing this entity

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

active · Rounds: 4 · Score: 0.74 · 2026-04-24

How do metabolomic alterations in glucose metabolism, mitochondrial function, an

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The abstract shows V1613M variant reduces amyloid plaques and damage in 5xFAD mi

closed · Rounds: 4 · Score: 0.60 · 2026-04-15

Related Research

Hypotheses and analyses mentioning AB in their description or question text

Optogenetic restoration of hippocampal gamma oscillations via selective PV inter

Score: 0.863 · Alzheimer's disease · 2026-04-07

## Mechanistic Overview Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activatio

Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stab

Score: 0.861 · Alzheimer's disease · 2026-04-05

## Mechanistic Overview Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization starts

TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Faile

Score: 0.858 · neurodegeneration · 2026-04-16

## Mechanistic Overview TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Transition

H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State

Score: 0.834 · neurodegeneration · 2026-04-22

## Mechanistic Overview H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State starts from the claim that

Ketone Utilization Index as Metabolic Flexibility Biomarker

Score: 0.819 · translational neuroscience · 2026-04-16

## Mechanistic Overview Ketone Utilization Index as Metabolic Flexibility Biomarker starts from the claim that modulatin

CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-Specific Vulnerabilit

Score: 0.811 · neurodegeneration · 2026-04-16

## Mechanistic Overview CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-Specific Vulnerability Thresholds sta

TREM2-mTOR Co-Agonism for Metabolic Reprogramming

Score: 0.803 · neurodegeneration · 2026-04-16

## Mechanistic Overview TREM2-mTOR Co-Agonism for Metabolic Reprogramming starts from the claim that modulating TREM2-mT

TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysregulation

Score: 0.800 · neurodegeneration · 2026-04-22

## Mechanistic Overview TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysregulation starts from the

SASP-Driven Microglial Metabolic Reprogramming in Synaptic Phagocytosis

Score: 0.796 · neurodegeneration · 2026-04-07

## Mechanistic Overview SASP-Driven Microglial Metabolic Reprogramming in Synaptic Phagocytosis starts from the claim th

Competitive APOE4 Domain Stabilization Peptides

Score: 0.784 · neurodegeneration · 2026-04-02

## Mechanistic Overview Competitive APOE4 Domain Stabilization Peptides starts from the claim that modulating APOE withi

H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from Epigenomic Homeostasi

Score: 0.770 · neurodegeneration · 2026-04-22

## Mechanistic Overview H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from Epigenomic Homeostasis starts from th

LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability in Diseas

Score: 0.770 · Alzheimer's Disease · 2026-04-05

## Mechanistic Overview LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability in Disease-Associated Mic

APOE4 astrocytes exhibit impaired cholesterol efflux via ABCA1/ABCG1 transporter

Score: 0.760 · neuroscience · 2026-04-22

## Mechanistic Overview APOE4 astrocytes exhibit impaired cholesterol efflux via ABCA1/ABCG1 transporters, driving intra

Dual-Circuit Tau Vulnerability Cascade

Score: 0.754 · neuroscience · 2026-04-07

## Mechanistic Overview Dual-Circuit Tau Vulnerability Cascade starts from the claim that modulating MAPT within the dis

Tau dysfunction destabilizes labile pool

Score: 0.750 · neurodegeneration · 2026-04-25

Loss of tau function (as in disease states) selectively destabilizes the labile microtubule population, disrupting axona

AB

Understanding Entity Pages

Wiki Pages (21)

AB

RAB9A

Ventral Pallidum GABAergic Neurons

KCNAB3 — Potassium Voltage-Gated Channel Subfamily A Member Beta 3

NAB-IT: Nabilone for Agitation in Alzheimer's Disease

RAB4B Gene

RAB35 — Ras-Associated Protein 35

RAB43 Gene

ABCA7 Protein

ABBV-951 Subcutaneous Infusion for Parkinson's Disease

ABCD1 — ATP Binding Cassette Subfamily D Member 1

RAB39B Endosomal-Lysosomal Dysfunction PD Causal Chain

RAB2A Gene

RABEP1

GABRA2 Gene

AB Science

GABRA1 Gene

GABRA4 Gene

ABCA7 (ATP-Binding Cassette Transporter A7)

GAB2 — GRB2 Associated Binding Protein 2

GABRA6 Gene

Outgoing (53)

Incoming (0)

Targeting Hypotheses (30)

Mentioning Analyses (4)

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

Metabolomic signatures of neurodegeneration and energy metabolism dysfunction

Experiments (11)

Related Papers (0)

Debates (3)

Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate bas

How do metabolomic alterations in glucose metabolism, mitochondrial function, an

The abstract shows V1613M variant reduces amyloid plaques and damage in 5xFAD mi

Related Research

Optogenetic restoration of hippocampal gamma oscillations via selective PV inter

Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stab

TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Faile

H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State

Ketone Utilization Index as Metabolic Flexibility Biomarker

CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-Specific Vulnerabilit

TREM2-mTOR Co-Agonism for Metabolic Reprogramming

TREM2 Deficiency Drives Microglial Senescence via Lipid Metabolism Dysregulation

SASP-Driven Microglial Metabolic Reprogramming in Synaptic Phagocytosis

Competitive APOE4 Domain Stabilization Peptides

H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from Epigenomic Homeostasi

LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability in Diseas

APOE4 astrocytes exhibit impaired cholesterol efflux via ABCA1/ABCG1 transporter

Dual-Circuit Tau Vulnerability Cascade

Tau dysfunction destabilizes labile pool